In Vivo Prime Gene Editing Used in First Patient Clinical Trial

Prime Medicine has introduced a direct gene correction treatment into a patient with Wilson disease via a single intravenous delivery. The approach targets genetic defects inside liver cells to potentially replace daily medication or organ transplants for affected individuals.